150 related articles for article (PubMed ID: 26870261)
21. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Romaguera JE; Fayad L; Rodriguez MA; Broglio KR; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Sarris AH; Dang NH; Wang M; Beasley V; Medeiros LJ; Katz RL; Gagneja H; Samuels BI; Smith TL; Cabanillas FF
J Clin Oncol; 2005 Oct; 23(28):7013-23. PubMed ID: 16145068
[TBL] [Abstract][Full Text] [Related]
22. Oesophageal involvement in mantle cell lymphoma.
Santra G
Singapore Med J; 2010 Dec; 51(12):e201-3. PubMed ID: 21221493
[TBL] [Abstract][Full Text] [Related]
23. Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
Fayad L; Thomas D; Romaguera J
Clin Lymphoma Myeloma; 2007 Dec; 8 Suppl 2():S57-62. PubMed ID: 18284717
[TBL] [Abstract][Full Text] [Related]
24. Primary colon mantle lymphoma: a misleading macroscopic appearance!
Arieira C; Dias de Castro F; Boal Carvalho P; Cotter J
Rev Esp Enferm Dig; 2019 Dec; 111(12):965-967. PubMed ID: 31663363
[TBL] [Abstract][Full Text] [Related]
25. VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Chang JE; Carmichael LL; Kim K; Peterson C; Yang DT; Traynor AM; Werndli JE; Huie MS; McFarland TA; Volk M; Blank J; Callander NS; Longo WL; Kahl BS
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e61-e67. PubMed ID: 29191715
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal involvement and multiple lymphomatous polyposis in mantle-zone lymphoma.
Triozzi PL; Borowitz MJ; Gockerman JP
J Clin Oncol; 1986 Jun; 4(6):866-73. PubMed ID: 3519878
[TBL] [Abstract][Full Text] [Related]
27. A rare case of mantle cell lymphoma as lymphomatous polyposis with widespread involvement of the digestive tract.
Chung Kim Yuen C; Tomowiak C; Yacoub M; Barrioz T; Barrioz C; Tougeron D
Clin Res Hepatol Gastroenterol; 2011 Jan; 35(1):74-8. PubMed ID: 21074342
[TBL] [Abstract][Full Text] [Related]
28. A case report of mantle cell lymphoma presenting as intussuscepting colon mass.
Smith BM; Reilly K; Baker E; Deeken A; Dan AG
Int J Surg Case Rep; 2020; 69():28-31. PubMed ID: 32248013
[TBL] [Abstract][Full Text] [Related]
29. Multiple lymphomatous polyposis with diffuse involvement of the gastrointestinal tract. Case report.
Cestaro G; De Rosa M; Vitiello C; Galloro G; Gentile M
G Chir; 2013; 34(5-6):173-5. PubMed ID: 23837958
[TBL] [Abstract][Full Text] [Related]
30. A Unique Case of Mantle Cell Lymphoma Masquerading as a Cecal Mass.
Herrera-Gonzalez S; Shamoon D; Shen T; Badin S; Bains Y
Case Rep Gastrointest Med; 2021; 2021():5581043. PubMed ID: 34545312
[TBL] [Abstract][Full Text] [Related]
31. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience.
Widmer F; Balabanov S; Soldini D; Samaras P; Gerber B; Manz MG; Goede JS
Ann Hematol; 2018 Feb; 97(2):277-287. PubMed ID: 29147847
[TBL] [Abstract][Full Text] [Related]
32. bc1-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis.
Kumar S; Krenacs L; Otsuki T; Kumar D; Harris CA; Wellmann A; Jaffe ES; Raffeld M
Am J Clin Pathol; 1996 Jun; 105(6):737-43. PubMed ID: 8659449
[TBL] [Abstract][Full Text] [Related]
33. Multiple lymphomatous polyposis of the gastrointestinal tract.
Isaacson PG; MacLennan KA; Subbuswamy SG
Histopathology; 1984 Jul; 8(4):641-56. PubMed ID: 6479906
[TBL] [Abstract][Full Text] [Related]
34. Endoscopic features and prognoses of mantle cell lymphoma with gastrointestinal involvement.
Iwamuro M; Okada H; Kawahara Y; Shinagawa K; Morito T; Yoshino T; Yamamoto K
World J Gastroenterol; 2010 Oct; 16(37):4661-9. PubMed ID: 20872966
[TBL] [Abstract][Full Text] [Related]
35. Complete Endoscopic and Histopathological Remission of Mantle Cell Lymphoma of the Gastrointestinal Tract.
Mohy-Ud-Din N; Guha A; Mitre M
Cureus; 2019 Mar; 11(3):e4350. PubMed ID: 31187015
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of rituximab plus Hyper-CVAD regimen in mantle cell lymphoma is independent of FCgammaRIIIa and FCgammaRIIa polymorphisms.
Galimberti S; Palumbo GA; Caracciolo F; Benedetti E; Pelosini M; Brizzi S; Ciabatti E; Fazzi R; Stelitano C; Quintana G; Conte E; Tibullo D; Di Raimondo F; Petrini M
J Chemother; 2007 Jun; 19(3):315-21. PubMed ID: 17594928
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal lymphomatous polyposis--clinical, endoscopical and evolution features. A case report.
Tanţău M; Tanţău A; Zaharia T; Cucuianu A
Rom J Gastroenterol; 2005 Sep; 14(3):273-8. PubMed ID: 16200239
[TBL] [Abstract][Full Text] [Related]
38. Synchronous Occurrence of Splenic Pleomorphic Mantle Cell Lymphoma and Esophageal Adenocarcinoma with Overexpression of BCL1 Protein.
Dabrowski D; Silva RF; Constantinescu M; Shackelford RE; Dela Cruz N; Wei EX
Case Rep Oncol Med; 2020; 2020():8888829. PubMed ID: 33425412
[TBL] [Abstract][Full Text] [Related]
39. Lymphomatous Interstitial Nephritis Coexistent with Paraneoplastic Crescentic Membranoproliferative Glomerulonephritis in a Case of Mantle Cell Lymphoma.
Etta PK; Rao MV; Reddy S; Gowrishankar S; Agarwal N
Indian J Nephrol; 2020; 30(3):192-195. PubMed ID: 33013070
[TBL] [Abstract][Full Text] [Related]
40. Multiple lymphomatous polyposis of the gut. A case with unusually widespread distribution.
Smir BN; Pulitzer DR
J Clin Gastroenterol; 1994 Sep; 19(2):139-42. PubMed ID: 7963362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
